Optune Archives -

Novocure’s Optune will be tested alongside investigational Celgene drug marizomib.

Celgene hopes device + drug can tackle aggressive brain tumours

https://pharmaphorum.com/news/celgene-optune/

Is digital the true solution to brain disorders?

Digital health round-up: Making a difference in brain disorders

https://pharmaphorum.com/views-and-analysis/digital-health-round-making-difference-brain-disorders/

Median overall survival improved from 15 months to 21 months when combined with chemotherapy.

Head patch device Optune improves brain cancer survival

https://pharmaphorum.com/news/head-patch-device-optune-improves-brain-cancer-survival/

Novocure’s Optune device shown to be safe and tolerable in recurrent ovarian cancer.

Electrical patch device shows promise against ovarian cancer

https://pharmaphorum.com/news/non-invasive-brain-tumour-patch-shows-promise-ovarian-cancer/

Optune